The pursuit of interventions that measurably slow biological aging has taken a significant step forward with evidence that something as mundane as a daily multivitamin can decelerate cellular aging processes. This finding challenges assumptions about the complexity required for anti-aging interventions and suggests accessible nutrition strategies may influence longevity at the molecular level.
The COSMOS trial tracked 958 adults for two years, measuring five established DNA methylation patterns that serve as biological age markers. Participants taking Centrum Silver showed meaningful reductions in aging velocity on two critical epigenetic clocks: PCGrimAge slowed by 0.113 years annually, while PCPhenoAge decelerated by 0.214 years per year. The effect was most pronounced among individuals already experiencing accelerated biological aging, where multivitamin use reduced PCGrimAge progression by nearly three months annually. Cocoa extract containing 500mg flavanols showed no measurable impact on any aging biomarker.
This represents the first large-scale randomized evidence that basic micronutrient supplementation can influence epigenetic aging clocks, biomarkers increasingly recognized as predictive of healthspan and mortality risk. The modest but consistent effects suggest multivitamins may help optimize cellular maintenance processes that typically decline with age. However, the mechanisms remain unclear, and the clinical significance of slowing epigenetic aging by 1-2 months yearly requires validation through longer studies measuring actual health outcomes. While promising for accessible longevity interventions, these findings represent early evidence in a field where replication and mechanistic understanding remain essential.
